Amundi Cuts Stock Position in Agilent Technologies, Inc. (NYSE:A)

by · The Markets Daily

Amundi cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 1.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,088,284 shares of the medical research company’s stock after selling 20,992 shares during the period. Amundi owned about 0.38% of Agilent Technologies worth $149,095,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of A. CKW Financial Group grew its position in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Agilent Technologies during the third quarter worth about $31,000. Hanson & Doremus Investment Management grew its position in shares of Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of Agilent Technologies during the third quarter worth about $38,000. 87.42% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A has been the subject of a number of research analyst reports. Citigroup upped their price target on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Robert W. Baird lowered their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Sanford C. Bernstein lowered their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Bank of America lowered their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Finally, Wells Fargo & Company lowered their price target on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average target price of $146.15.

View Our Latest Analysis on A

Agilent Technologies Price Performance

A stock opened at $122.02 on Tuesday. The company has a market capitalization of $34.79 billion, a P/E ratio of 28.05, a PEG ratio of 3.56 and a beta of 1.11. Agilent Technologies, Inc. has a twelve month low of $121.45 and a twelve month high of $155.35. The business has a 50 day simple moving average of $139.42 and a 200-day simple moving average of $138.55. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.81%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.76%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.26% of the company’s stock.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories